• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Calciless
    / SAM-ON

    Active Ingredient *
    Potassium Phosphate (monobasic) 602 mg
    Sodium Phosphate (dibasic) 285 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft



    full basket chart 417 3012

    Related information


    3 tablets on the first day, followed by 2 tablets 3 times a day, with meals.
    Refer to the license holder for further details.           


    Prevention and treatment of calcium oxalate stones.


    Hypersensitivity, severe renal impairment, hyperphosphatemia, urolithiasis.

    Special Precautions

    Patients with kidney stones should be warned of the possibility of passing old stones at the start of phosphate therapy. Monitor renal function, serum calcium, phosphorus, potassium and sodium. Alcohol, smoking and excessive exposure to direct sunlight should be avoided.
    Refer to the license holder for further details.

    Side Effects

    Discomfort, pain or fullness in the upper abdomen. These may be overcome by increasing the dosage gradually. Nausea and vomiting may occur at the beginning of treatment. Headaches, dizziness, seizures, weakness or fatigue, numbness, tingling or swelling of hands or legs, and thirst.
    Refer to the license holder for further details.

    Important notes

    Sodium content – approx. 90 mg.

    Sam-On Ltd., Israel
    Licence holder